Neurologix Announces Third Quarter 2009 Financial Results

FORT LEE, N.J.--(BUSINESS WIRE)--Neurologix, Inc. (OTCBB: NRGX) (the “Company”), a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, announced today its financial results for the third quarter and nine months ended September 30, 2009. For the three months ended September 30, 2009, the Company reported a net loss of $3.5 million, as compared with a net loss of $1.6 million for the three months ended September 30, 20

For more information, please visit
http://www.businesswire.com/news/home/20091112005078/en

You need to login to post comments.

Feed last updated 1969/12/31 @7:00 PM

0 COMMENTS:

VOCAPIA and SYSTRAN demonstrate an automated speech translation solution at EUROSATORY 2016 - GlobeNewswire (press release) views: 1543

Instagram is adding automatic in-app text translation - The Verge views: 1530

Here’s a ‘Brand-New’ Massive Multilingual Dataset for Machine Translation views: 1529

F.A.Q. | Terms and conditions